BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Medical & Biological Laboratories Company Limited
sales of 7.17 billion Japanese Yen [US$68.92 million]
of which 100%
was Reagent business),
Falco Sd Holdings Company Limited
(58.40 billion Japanese Yen [US$561.23 million]
Miraca Holdings Incorporated
(203.37 billion Japanese Yen [US$1.95 billion]
of which 65%
was Clinical Examination).
BML Inc reported sales of ¥99.05 billion (US$951.84 million)
March of 2014.
increase of 4.7%
versus 2013, when the company's sales were ¥94.61 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2009, sales have increased a total of 28%).